Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

Abstract Background The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two experimental regimens containing moxifloxacin. Me...

Full description

Bibliographic Details
Main Authors: Conor D. Tweed, Angela M. Crook, Evans I. Amukoye, Rodney Dawson, Andreas H. Diacon, Madeline Hanekom, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Michael E. Murphy, Saraswathi E. Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Genevieve H. Wills, Stephen H. Gillespie
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Infectious Diseases
Subjects:
Tuberculosis
Toxicity
Clinical trials
Adverse events
Online Access:http://link.springer.com/article/10.1186/s12879-018-3230-6

Internet

http://link.springer.com/article/10.1186/s12879-018-3230-6

Similar Items